Nephrology Doctors in Trumbull, CT Accepting Medicare

4 Nephrology doctors found. Showing 1 - 4

Robert Chai Kim, M.D. Internal Medicine - Nephrology Medicare: May Accept Medicare Assignments Practice Location: 7 Cambridge Dr Ste 201, Trumbull, CT 06611 Phone: 203-335-0195    Fax: 203-335-7293

William Allen Hunt, MD Internal Medicine - Nephrology Medicare: May Accept Medicare Assignments Practice Location: 7 Cambridge Dr Ste 201, Trumbull, CT 06611 Phone: 203-335-0195    Fax: 203-335-7293

James Patrick Gavin, M.D. Internal Medicine - Nephrology Medicare: May Accept Medicare Assignments Practice Location: 7 Cambridge Dr Ste 201, Trumbull, CT 06611 Phone: 203-335-0195    Fax: 203-335-7293

Irwin David Feintzeig, M.D. Internal Medicine - Nephrology Medicare: May Accept Medicare Assignments Practice Location: 7 Cambridge Dr Ste 201, Trumbull, CT 06611 Phone: 203-335-0195    Fax: 203-335-7293

News Archive

Real-time elastography method depicts liver hardness: Study

Palpation continues to be of great value in modern medicine, both practiced by doctors and as a technique for self-examination. However, palpation is limited to a few accessible organs, and the interpretation of the information sensed by the fingers is highly subjective.

Patients with advanced NSCLC predict their overall survival rates

Research published in the September 2009 issue of the Journal of Thoracic Oncology has found that an individual's quality of life prior to treatment can help predict the overall survival of patients with advanced stage non-small cell lung cancer (NSCLC).

Centice launches integration and solutions platform for Computational Raman Spectroscopy application

Centice Corporation, a pioneer in chemical verification and identification using Raman Spectroscopy and computational sensor technology, announced today the availability of an integration and solutions platform for the application of Computational Raman Spectroscopy to satisfy technology needs in process manufacturing, healthcare, public safety and materials science.

Human Genome Sciences achieves systemic lupus goals with candidate drug

Human Genome Sciences announced that BENLYSTA™ met the primary endpoint in BLISS-52, the first of two pivotal Phase 3 trials in patients with serologically active systemic lupus erythematosus (SLE). These results show that BENLYSTA™ has the potential to become the first new approved drug in decades giving hope to people living with systemic lupus.

Read more Medical News

› Verified 4 days ago